Real-time Estimate
Cboe BZX
11:37:01 2024-05-22 am EDT
|
5-day change
|
1st Jan Change
|
9.42
USD
|
+1.62%
|
|
+9.12%
|
-8.70%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
653
|
518.8
|
464.9
|
-
|
-
|
Enterprise Value (EV)
1 |
1,213
|
1,044
|
978.3
|
945.1
|
952
|
P/E ratio
|
10.4
x
|
-6.43
x
|
46.4
x
|
32.9
x
|
42.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.6
x
|
0.5
x
|
0.43
x
|
0.41
x
|
0.39
x
|
EV / Revenue
|
1.12
x
|
1
x
|
0.91
x
|
0.84
x
|
0.81
x
|
EV / EBITDA
|
7.62
x
|
10.7
x
|
9.6
x
|
8.77
x
|
8.16
x
|
EV / FCF
|
16.6
x
|
23.3
x
|
25.1
x
|
20.7
x
|
-
|
FCF Yield
|
6.02%
|
4.3%
|
3.98%
|
4.84%
|
-
|
Price to Book
|
0.77
x
|
0.77
x
|
0.68
x
|
0.66
x
|
0.64
x
|
Nbr of stocks (in thousands)
|
49,618
|
50,130
|
50,155
|
-
|
-
|
Reference price
2 |
13.16
|
10.35
|
9.270
|
9.270
|
9.270
|
Announcement Date
|
2/15/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,083
|
1,046
|
1,077
|
1,124
|
1,182
|
EBITDA
1 |
-
|
159.3
|
97.6
|
101.9
|
107.7
|
116.6
|
EBIT
1 |
-
|
107.6
|
66.7
|
66.78
|
71.62
|
84.06
|
Operating Margin
|
-
|
9.93%
|
6.37%
|
6.2%
|
6.37%
|
7.11%
|
Earnings before Tax (EBT)
1 |
-
|
93.5
|
-90.4
|
17.51
|
24.05
|
26.86
|
Net income
1 |
111.1
|
62.5
|
-80.5
|
9.839
|
14.39
|
11.29
|
Net margin
|
-
|
5.77%
|
-7.69%
|
0.91%
|
1.28%
|
0.95%
|
EPS
2 |
-
|
1.260
|
-1.610
|
0.2000
|
0.2820
|
0.2200
|
Free Cash Flow
1 |
-
|
73
|
44.9
|
38.95
|
45.72
|
-
|
FCF margin
|
-
|
6.74%
|
4.29%
|
3.62%
|
4.07%
|
-
|
FCF Conversion (EBITDA)
|
-
|
45.83%
|
46%
|
38.22%
|
42.43%
|
-
|
FCF Conversion (Net income)
|
-
|
116.8%
|
-
|
395.85%
|
317.79%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/4/22
|
2/15/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
268
|
265.7
|
275.1
|
265.1
|
262.3
|
258.3
|
260.6
|
262.4
|
267.4
|
272.1
|
274.4
|
276.8
|
277
|
EBITDA
1 |
40.3
|
31.7
|
40.3
|
25.3
|
23.9
|
23.2
|
25.2
|
25.3
|
24.54
|
25.38
|
27.03
|
25.87
|
26.66
|
EBIT
1 |
32.1
|
23.7
|
27
|
14.2
|
16.2
|
15.5
|
17.5
|
12.9
|
16.3
|
17.1
|
18.75
|
17.72
|
18.91
|
Operating Margin
|
11.98%
|
8.92%
|
9.81%
|
5.36%
|
6.18%
|
6%
|
6.72%
|
4.92%
|
6.1%
|
6.28%
|
6.83%
|
6.4%
|
6.83%
|
Earnings before Tax (EBT)
1 |
-
|
11.7
|
19.2
|
4.2
|
-84.7
|
-3
|
-7.4
|
1.1
|
2.916
|
4.806
|
6.94
|
4.121
|
5.301
|
Net income
1 |
20.34
|
8.6
|
7.7
|
2.7
|
-74.4
|
-2.4
|
-6.4
|
-
|
1.923
|
2.848
|
4.375
|
2.783
|
2.062
|
Net margin
|
7.59%
|
3.24%
|
2.8%
|
1.02%
|
-28.36%
|
-0.93%
|
-2.46%
|
-
|
0.72%
|
1.05%
|
1.59%
|
1.01%
|
0.74%
|
EPS
2 |
0.4100
|
0.1700
|
0.1500
|
0.0500
|
-1.490
|
-0.0500
|
-0.1300
|
0.0100
|
0.0300
|
0.0680
|
0.0850
|
0.0567
|
0.0400
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/1/22
|
11/1/22
|
2/15/23
|
5/9/23
|
8/9/23
|
11/7/23
|
3/6/24
|
5/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
560
|
525
|
513
|
480
|
487
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
3.517
x
|
5.381
x
|
5.037
x
|
4.456
x
|
4.176
x
|
Free Cash Flow
1 |
-
|
73
|
44.9
|
38.9
|
45.7
|
-
|
ROE (net income / shareholders' equity)
|
-
|
6.55%
|
1.59%
|
2.05%
|
3.09%
|
3.54%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
17.00
|
13.40
|
13.60
|
14.00
|
14.50
|
Cash Flow per Share
2 |
-
|
1.610
|
0.9700
|
1.000
|
1.150
|
-
|
Capex
1 |
-
|
7.1
|
3.5
|
7.11
|
7.29
|
8.35
|
Capex / Sales
|
-
|
0.66%
|
0.33%
|
0.66%
|
0.65%
|
0.71%
|
Announcement Date
|
4/4/22
|
2/15/23
|
3/6/24
|
-
|
-
|
-
|
Last Close Price
9.27
USD Average target price
9.75
USD Spread / Average Target +5.18% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.70% | 465M | | +1.28% | 3.14B | | 0.00% | 1.91B | | +19.47% | 1.79B | | +69.07% | 711M | | -45.44% | 306M | | -17.54% | 173M | | -16.25% | 133M | | +3.85% | 69.19M |
Home Healthcare Services
|